Follow the people · Insider

AC

Adam Crystal

Insider · President, R&D · TNGX

Adam Crystal files insider transactions with the SEC as a president, r&d of Tango Therapeutics (TNGX). We hold 11 disclosed purchases and sales filed since 16 February 2021, 3 of them in the last 90 days.

  • Files forTNGX
  • Disclosed buys and sells11 in all, 3 in the last 90 days
  • Last disclosure3 September 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 1 March 20231 September 2026President, R&D · Tango Therapeutics (TNGX)54 Form 4 lines · source: SEC Form 4
  • Filed 11 February 202130 January 2023Chief Medical Officer · C4 Therapeutics (CCCC)33 Form 4 lines · source: SEC Form 4

Everything they disclosed

87 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.